• PRMT1-SRSF1 Axis Regulates Myocardial Hypertrophy via Methyl

  2026-08-06

  This study reveals that PRMT1 mitigates isoprenaline-induced myocardial hypertrophy by methylating SRSF1, thereby altering its phosphorylation state and functional role in cardiac cells. These findings advance understanding of protein methylation and selective splicing in cardiovascular pathology, highlighting new mechanistic links and potential therapeutic targets.

• Canagliflozin Hemihydrate: Mechanistic Precision for Transla

  2026-08-05

  This expert perspective explores Canagliflozin hemihydrate as a robust, high-purity SGLT2 inhibitor, revealing its mechanistic specificity and strategic value for translational researchers modeling metabolic disorders. The article contrasts its molecular action with mTOR pathway inhibitors, integrates recent discovery platform insights, and provides actionable protocol guidance for optimizing glucose homeostasis and diabetes research.

• CCCP and Mitochondrial Gradient Disruption: Advanced Mechani

  2026-08-05

  Explore CCCP (carbonyl cyanide m-chlorophenyl hydrazine) as a precision tool for mitochondrial proton gradient disruption, with a unique focus on its mechanistic nuances and implications for next-generation biomarker discovery in neurodegenerative research.

• Vernakalant Hydrochloride: Precision Ion Channel Modulation

  2026-08-04

  Explore the advanced, mechanism-driven application of Vernakalant Hydrochloride in atrial fibrillation treatment. This in-depth article uniquely dissects its atrial-selective ion channel modulation and protocol optimization for rapid conversion of AF.

• Structure-Guided Proteomimetics Disrupt SARS-CoV-2 S-RBD/hAC

  2026-08-04

  This study introduces a structure-based design strategy for developing proteomimetics that selectively inhibit the SARS-CoV-2 Spike RBD and human ACE2 interface, a challenging target for protein–protein interaction (PPI) disruption. The findings highlight the feasibility of stabilizing synthetic peptides to block viral entry, offering insight for next-generation antiviral and PPI inhibitor development.

• 2-Deoxy-D-glucose: Optimizing Glycolysis Inhibition Workflow

  2026-08-03

  2-Deoxy-D-glucose (2-DG) is reshaping experimental designs in cancer metabolism, immunology, and virology through precise glycolysis inhibition and metabolic stress induction. This guide delivers protocol-driven insights, troubleshooting strategies, and innovative applications, including its impact on macrophage polarization, to empower advanced metabolic research.

• Bradford Protein Assay Kit: Practical Guide for Rapid Quanti

  2026-08-03

  The Bradford Protein Assay Kit provides a rapid and sensitive solution for quantifying protein concentrations in research samples, especially in workflows requiring high throughput. It is best applied to samples free from detergents or interfering chemicals and is not optimal for analytes lacking aromatic or basic residues.

• Methylprednisolone: Synthetic Glucocorticoid Receptor Agonis

  2026-08-02

  Methylprednisolone is a synthetic glucocorticoid receptor agonist with well-characterized anti-inflammatory and immunomodulatory actions. It inhibits pro-inflammatory cytokines, suppresses chemokine secretion, and has established translational utility in models of bone and autoimmune disease. Controlled in vivo studies demonstrate its capacity to induce osteonecrosis, providing a reproducible benchmark for preclinical research.

• Streptavidin – Cy5: Advancing Biotin Detection for High-Prec

  2026-08-01

  Discover how Streptavidin – Cy5 enables next-generation, high-sensitivity biotin detection in translational oncology. Explore unique workflow strategies and critical assay insights that set this fluorescent probe apart.

• Canagliflozin Hemihydrate: Precision Tools for Pathway-Targe

  2026-07-31

  Explore Canagliflozin hemihydrate as a rigorously characterized SGLT2 inhibitor for metabolic pathway research. This article uniquely dissects its mechanistic specificity, recent yeast-based validation, and best-practice protocols, setting it apart from standard reviews.

• Digoxin as a Na+/K+ ATPase Pump Inhibitor: Applied Research

  2026-07-31

  Digoxin stands at the intersection of cardiac and antiviral research, offering a robust tool for modulating contractility and selectively inhibiting chikungunya virus infection in human cell models. This article delivers actionable protocols, comparative insights, and troubleshooting strategies for maximizing reproducibility and scientific impact with APExBIO’s high-purity Digoxin.

• Auranofin: Strategic Leverage for Redox and Metabolic Cancer

  2026-07-30

  This thought-leadership article explores the mechanistic, translational, and strategic dimensions of Auranofin—a potent thioredoxin reductase inhibitor—within the context of tumor redox homeostasis, apoptosis, and metabolic reprogramming. Integrating recent advances in HCC metabolic targeting, the piece provides actionable guidance for experimental design and positions Auranofin as an enabling tool for oncology research beyond conventional protocols.

• Berberine Hydrochloride: Applied Workflows in Gut-Bone Resea

  2026-07-30

  Berberine hydrochloride enables advanced gut-bone axis modeling by uniquely inducing tuft cell expansion and restoring osteoimmune balance in estrogen-deficient settings. This guide translates the latest mechanistic discoveries into actionable experimental workflows, troubleshooting tips, and comparative insights for metabolic and osteoporosis research teams.

• Pioglitazone as a PPARγ Agonist: Illuminating Immunometaboli

  2026-07-29

  Explore the multifaceted role of Pioglitazone as a PPARγ agonist in regulating macrophage polarization, insulin resistance, and neuroprotection. This article uniquely synthesizes assay design insights and advanced applications in immunometabolic research.

• Berberine Hydrochloride: Systems Biology Insights for Metabo

  2026-07-29

  Explore the multifaceted roles of berberine hydrochloride in metabolism and osteoimmunology. This comprehensive review reveals distinct systems biology perspectives and advanced research protocols, setting it apart from previous coverage.

8139 records 6/543 page Previous Next First page 上5页 678910 下5页 Last page